Punjab Chemicals & Crop Protection Ltd
Incorporated in 1975, Punjab Chemicals
& Crop Protection Ltd is in the business
of Performance Chemicals[1]
- Market Cap ₹ 1,553 Cr.
- Current Price ₹ 1,267
- High / Low ₹ 1,495 / 662
- Stock P/E 36.2
- Book Value ₹ 297
- Dividend Yield 0.24 %
- ROCE 15.1 %
- ROE 12.0 %
- Face Value ₹ 10.0
Pros
Cons
- The company has delivered a poor sales growth of 10.4% over past five years.
- Dividend payout has been low at 7.35% of profits over last 3 years
- Debtor days have increased from 76.4 to 95.6 days.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Commodities Chemicals Fertilizers & Agrochemicals Pesticides & Agrochemicals
Part of BSE SmallCap BSE Allcap BSE Commodities
Quarterly Results
Standalone Figures in Rs. Crores / View Consolidated
Profit & Loss
Standalone Figures in Rs. Crores / View Consolidated
Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
416 | 409 | 356 | 411 | 488 | 640 | 548 | 676 | 931 | 1,004 | 931 | 898 | |
381 | 365 | 331 | 405 | 454 | 574 | 506 | 582 | 792 | 882 | 818 | 799 | |
Operating Profit | 36 | 44 | 26 | 5 | 34 | 66 | 41 | 94 | 139 | 122 | 112 | 99 |
OPM % | 9% | 11% | 7% | 1% | 7% | 10% | 8% | 14% | 15% | 12% | 12% | 11% |
13 | 8 | 47 | 29 | 15 | 2 | 19 | 1 | 0 | 4 | 3 | -3 | |
Interest | 32 | 32 | 21 | 22 | 18 | 17 | 18 | 12 | 12 | 18 | 19 | 18 |
Depreciation | 15 | 18 | 15 | 14 | 14 | 19 | 15 | 15 | 17 | 19 | 22 | 25 |
Profit before tax | 1 | 4 | 36 | -1 | 17 | 32 | 27 | 68 | 110 | 89 | 74 | 54 |
Tax % | 0% | 0% | 0% | 53% | 40% | 37% | 42% | 26% | 27% | 31% | 26% | 26% |
1 | 4 | 36 | -2 | 10 | 20 | 16 | 51 | 81 | 61 | 54 | 40 | |
EPS in Rs | 0.96 | 2.90 | 29.05 | -1.71 | 8.48 | 16.51 | 12.87 | 41.22 | 65.91 | 49.70 | 44.40 | 32.43 |
Dividend Payout % | 0% | 0% | 0% | 0% | 0% | 9% | 12% | 5% | 5% | 6% | 7% | 9% |
Compounded Sales Growth | |
---|---|
10 Years: | 8% |
5 Years: | 10% |
3 Years: | -1% |
TTM: | -3% |
Compounded Profit Growth | |
---|---|
10 Years: | 23% |
5 Years: | 22% |
3 Years: | -19% |
TTM: | -20% |
Stock Price CAGR | |
---|---|
10 Years: | 19% |
5 Years: | 22% |
3 Years: | 2% |
1 Year: | -11% |
Return on Equity | |
---|---|
10 Years: | 20% |
5 Years: | 22% |
3 Years: | 17% |
Last Year: | 12% |
Balance Sheet
Standalone Figures in Rs. Crores / View Consolidated
Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Equity Capital | 12 | 12 | 12 | 12 | 12 | 12 | 12 | 12 | 12 | 12 | 12 | 12 |
Reserves | 7 | 7 | 42 | 60 | 70 | 89 | 102 | 152 | 229 | 286 | 336 | 352 |
323 | 282 | 170 | 143 | 117 | 91 | 99 | 88 | 93 | 94 | 123 | 168 | |
128 | 119 | 135 | 142 | 169 | 192 | 200 | 219 | 239 | 242 | 197 | 268 | |
Total Liabilities | 470 | 420 | 359 | 357 | 368 | 384 | 413 | 470 | 574 | 634 | 669 | 801 |
234 | 221 | 175 | 169 | 177 | 180 | 168 | 189 | 212 | 222 | 236 | 254 | |
CWIP | 1 | 7 | 4 | 6 | 4 | 7 | 15 | 16 | 7 | 20 | 12 | 13 |
Investments | 3 | 4 | 4 | 5 | 1 | 1 | 1 | 1 | 1 | 2 | 8 | 4 |
232 | 190 | 176 | 177 | 186 | 197 | 230 | 265 | 354 | 390 | 413 | 529 | |
Total Assets | 470 | 420 | 359 | 357 | 368 | 384 | 413 | 470 | 574 | 634 | 669 | 801 |
Cash Flows
Standalone Figures in Rs. Crores / View Consolidated
Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
36 | 48 | 81 | 48 | 58 | 69 | 32 | 47 | 32 | 57 | 29 | 23 | |
-2 | -0 | 12 | -8 | -15 | -21 | -14 | -14 | -27 | -36 | -36 | -28 | |
-15 | -65 | -97 | -40 | -43 | -4 | -19 | -23 | -9 | -20 | 5 | 12 | |
Net Cash Flow | 19 | -17 | -5 | 0 | 1 | 45 | 0 | 10 | -4 | 1 | -1 | 7 |
Ratios
Standalone Figures in Rs. Crores / View Consolidated
Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Debtor Days | 60 | 52 | 57 | 43 | 31 | 35 | 32 | 45 | 44 | 52 | 81 | 96 |
Inventory Days | 104 | 87 | 82 | 83 | 83 | 75 | 97 | 91 | 99 | 97 | 85 | 151 |
Days Payable | 112 | 92 | 101 | 122 | 131 | 103 | 100 | 102 | 84 | 79 | 75 | 136 |
Cash Conversion Cycle | 52 | 48 | 38 | 4 | -17 | 7 | 29 | 35 | 58 | 70 | 91 | 110 |
Working Capital Days | 7 | -30 | -5 | -7 | -0 | 8 | 19 | 23 | 45 | 56 | 84 | 104 |
ROCE % | 11% | 12% | 8% | 10% | 15% | 30% | 22% | 34% | 42% | 29% | 21% | 15% |
Documents
Announcements
- Closure of Trading Window 1d
-
Communication To Shareholders - Deduction Of Tax At Source On Dividend
19 Jun - Dividend of INR 3/share announced; detailed TDS tax deduction guidelines for shareholders provided.
-
Compliances-Reg.24(A)-Annual Secretarial Compliance
23 May - Annual Secretarial Compliance Report for FY 2024-25 confirming full SEBI compliance.
-
Announcement under Regulation 30 (LODR)-Earnings Call Transcript
7 May - Transcript of Earnings Call Q4 & FY25 held on May 2, 2025.
-
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
5 May - Scheduled investor meeting on May 9, 2025, with SVAN Investment; no UPSI to be discussed.
Annual reports
-
Financial Year 2024
from bse
-
Financial Year 2023
from bse
-
Financial Year 2022
from bse
-
Financial Year 2021
from bse
-
Financial Year 2020
from bse
-
Financial Year 2019
from bse
-
Financial Year 2018
from bse
-
Financial Year 2017
from bse
-
Financial Year 2016
from bse
-
Financial Year 2015
from bse
-
Financial Year 2014
from bse
-
Financial Year 2013
from nse
-
Financial Year 2013
from bse
-
Financial Year 2012
from bse
-
Financial Year 2011
from bse
Concalls
-
May 2025Transcript PPT REC
-
Jan 2025Transcript PPT
-
Oct 2024Transcript PPT
-
Aug 2024Transcript PPT
-
May 2024Transcript PPT REC
-
Feb 2024Transcript PPT REC
-
Nov 2023Transcript PPT REC
-
Aug 2023Transcript PPT REC
-
May 2023Transcript PPT REC
-
May 2023TranscriptNotesPPT
-
Feb 2023Transcript PPT REC
-
Nov 2022Transcript PPT
-
Aug 2022Transcript PPT
-
May 2022TranscriptNotesPPT
-
May 2022Transcript PPT
-
Feb 2022Transcript PPT
-
Nov 2021Transcript PPT
-
Aug 2021Transcript PPT
-
Jun 2021TranscriptNotesPPT
-
Jan 2021TranscriptNotesPPT
-
Nov 2020TranscriptNotesPPT
Business Overview:[1]
PCCPL operates in Agrochemicals, Pharmaceuticals, and Industrial Chemicals, offering Contract Research and Manufacturing Services (CRAMS) with a focus on innovation.